Skip to main content
. 2021 May 10;4(5):e218055. doi: 10.1001/jamanetworkopen.2021.8055

Table 2. Attribution of Patients With Newly Diagnosed Cancer to Medical Oncology, Surgery, and Radiation Oncology Practices.

Practice assignment Type of cancer, No. (%) or No./total No. (%)a
Breast (n = 78 736) Colorectal (n = 51 385) Lung (n = 95 635) Prostate (n = 75 571)
Proportion of patients attributed to practices based on visits in the 6 mo after diagnosis
Assigned to any practice type
Based on outpatient visits 72 291 (91.8) 40 054 (77.9) 70 854 (74.1) 67 390 (89.2)
Based on outpatient and inpatient visits 73 258 (93.0) 46 439 (90.4) 83 797 (87.6) 68 201 (90.2)
Based on outpatient visits, stratified by cancer stage
Stage I 33 036/33 942 (97.3) 9384/12 225 (76.8) 19 129/23 132 (82.7) 399/681 (58.6)
Stage II 19 684/20 440 (96.3) 11 734/14 316 (82.0) 3478/3996 (87.0) 51 946/57 896 (89.7)
Stage III 5448/5698 (95.6) 11 011/12 810 (86.0) 17 128/22 326 (76.7) 4840/5122 (94.5)
Stage IV 3304/4138 (79.8) 7212/10 482 (68.8) 29 033/42 541 (68.2) 6975/8288 (84.2)
Assigned to any medical oncology practiceb
Based on outpatient visits 56 884 (72.2) 27 857 (54.2) 53 635 (56.1) 8010 (10.6)
Based on outpatient and inpatient visits 57 631 (73.2) 31 647 (61.6) 62 458 (65.3) 8548 (11.3)
Based on outpatient visits by cancer stage
Stage I 27 453/33 942 (80.9) 4163/12 225 (34.1) 10 468/23 132 (45.3) 8/681 (1.2)
Stage II 16 888/20 440 (82.6) 7969/14 316 (55.7) 2870/3996 (71.8) 3658/57 896 (6.3)
Stage III 4817/5698 (84.5) 9238/12 810 (72.1) 14 361/22 326 (64.3) 491/5122 (9.6)
Stage IV 2939/4138 (71.0) 6114/10 482 (58.3) 24 651/42 541 (57.9) 3640/8288 (43.9)
Assigned to any surgical practice
Based on surgery claim 65 849 (83.6) 36 733 (71.5) 16 939 (17.7) 13 974 (18.5)
Based on surgery claim or visit to a surgeon 73 599 (93.5) 42 993 (83.7) 35 527 (37.1) 67 722 (89.6)
Stratified by cancer stage
Stage I 23 928/33 942 (97.0) 10 375/12 225 (84.9) 15 296/23 132 (66.1) 552/681 (81.1)
Stage II 19 482/20 440 (95.3) 13 497/14 316 (94.3) 2550/3996 (63.8) 52 803/57 896 (91.2)
Stage III 5301/5698 (93.0) 12 051/12 810 (94.1) 7818/22 326 (35.0) 4846/5122 (94.6)
Stage IV 2208/4138 (53.4) 6166/10 482 (58.8) 8506/42 541 (20.0) 6200/8288 (74.8)
Assigned to any radiation oncology practice
Based on radiation claim 9432 (12.0) 1647 (3.2) 8404 (8.8) 11 503 (15.2)
Based on radiation claim or visit to a radiation oncologist 42 221 (53.6) 6083 (11.8) 34 086 (35.6) 34 208 (45.3)
Stratified by cancer stage
Stage I 21 647/33 942 (63.8) 1108/12 225 (9.1) 7998/23 132 (34.6) 32/681 (4.7)
Stage II 9769/20 440 (47.8) 1823/14 316 (12.7) 1680/3996 (42.0) 28 480/57 896 (49.2)
Stage III 2250/5698 (39.5) 2053/12 810 (16.0) 9771/22 326 (43.8) 2002/5122 (39.1)
Stage IV 1011/4138 (24.4) 936/10 482 (8.9) 13 799/42 541 (32.4) 2240/8288 (27.0)
Proportion of patients with cancer-related visits to >1 practice in the 6 mo after diagnosis
Outpatients with visits to >1 practice of any type 56 223/78 736 (71.4) 26 084/51 385 (50.8) 47 774/95 635 (50.0) 42 812/75 571 (56.7)
Outpatients with any visits to medical oncology practiceb
Outpatients with visits to >1 medical oncology practice 4489/56 684 (7.9) 2285/27 857 (8.2) 5492/53 635 (10.2) 599/8010 (7.5)
Outpatients with only 1 visit to medical oncology practice 12 443/56 684 (21.9) 6467/27 857 (23.2) 11 181/53 635 (20.8) 3218/8010 (40.2)
Outpatients with surgery visits or surgery
Outpatients with surgical visits or surgical procedures from >1 surgery practice 15 184/73 599 (20.6) 9540/42 993 (22.2) 5522/35 527 (15.5) 15 338/67 722 (22.6)
Outpatients with ≥1 radiation oncology visit or radiation
Outpatients with visits to or radiation therapy from > l radiation oncology practice 2313/42 221 (5.5) 268/6083 (4.4) 1925/34 086 (5.6) 3593/34 208 (10.5)
a

Percentages may not total 100 because of rounding.

b

A visit to a medical oncology practice was defined as a claim with a specialty code of medical oncology, hematology/oncology, hematology, or gynecologic oncology.